7004 Final results of a randomized phase II study of OGX-011 (OGX) in combination with docetaxel (DOC)/prednisone versus docetaxel/prednisone in patients with metastatic castration resistant prostate cancer (CRPC)

Chi, K.N.; Hotte, S.J.; Yu, E.; Tu, D.; Eigl, B.; Tannock, I.; Saad, F.; North, S.; Powers, J.; Eisenhauer, E.

期刊名称European Journal of Cancer Supplements
作者Chi, K.N.; Hotte, S.J.; Yu, E.; Tu, D.; Eigl, B.; Tannock, I.; Saad, F.; North, S.; Powers, J.; Eisenhauer, E.
卷第7卷
期第2期
印刷ISSN1359-6349
文件大小52.51KB
发表时间2009-9
DOI10.1016/S1359-6349(09)71382-5

发现好书期刊，享受阅读乐趣